We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Treatment of Microplastics from Pharmaceutical Industrial Wastewater
Summary
Pharmaceutical manufacturing generates wastewater containing microplastics from plastic equipment, packaging, and processing materials, a source of contamination that surged during the COVID-19 pandemic as drug production ramped up. This review examines the nature of microplastic contamination in pharmaceutical wastewater and evaluates treatment techniques for removing these particles before discharge. Addressing this overlooked industrial source is important for reducing microplastic loads entering water systems from healthcare and pharmaceutical infrastructure.
The ubiquity of microplastics in the effluents produced during pharmaceutical manufacturing operations has made the presence of these particles in pharmaceutical industry wastewater a significant environmental concern. The growing importance of the pharmaceutical sector emphasizes even more how urgent it is to address microplastic contamination as a serious environmental issue that has to be addressed right now and requires the application of efficient mitigation techniques. During the pandemic, a significant increase in microplastics was found in pharmaceutical industry trash. It is imperative to address the issues brought on by the varied makeup of microplastics obtained from the pharmaceutical sector. Identification and classification procedures become more difficult when polymers are added to medication formulations, packaging materials, and equipment because they combine to generate a complex mixture of microplastics. Investigating tactics that combine bio-based adsorbents with nanomaterials is crucial since these methods have shown promise in lab settings and may be solutions. Present wastewater treatment techniques, such as membrane filtration, activated carbon adsorption, and ultrasonic degradation, have the potential to enhance efficacy of removal of microplastic from wastewater. They do, however, have limits in terms of completely getting rid of microplastics. For example, ozonation can change a polymer’s structure without appreciably lowering the presence of microplastic residues. Thus, more sophisticated approaches have been devised to intensify the treatment of microplastics, such as the utilization of magnetic polyoxometalate-supported ionic liquid phases. The treatment of microplastics from pharmaceutical industry effluent necessitates a thorough and interdisciplinary approach, as this chapter emphasizes. Through the adoption of technological innovations, strict regulations, and sustainable practices, the pharmaceutical business may effectively contribute to reducing the environmental impact of microplastics and promoting a cleaner, more sustainable future.
Sign in to start a discussion.
More Papers Like This
Pharmaceutically active micropollutants: origin, hazards and removal
This review summarizes existing research on pharmaceutical pollutants -- such as antibiotics, painkillers, and hormones -- found in water systems around the world. While focused on drug contamination, the paper notes that microplastics can act as carriers for these pharmaceutical chemicals, potentially concentrating them and increasing human exposure through drinking water. Conventional water treatment methods are often unable to fully remove these micropollutants.
The Occurrence of Micropollutants in the Aquatic Environment and Technologies for Their Removal
This review summarizes the growing problem of micropollutants in water, including microplastics, pharmaceuticals, and industrial chemicals, and evaluates advanced treatment methods to remove them. The research is important for human health because conventional water treatment plants cannot effectively filter out these contaminants, meaning people may be regularly exposed through tap water.
Sustainable treatment systems for removal of pharmaceutical residues and other priority persistent substances
This review evaluates sustainable wastewater treatment technologies for removing pharmaceutical residues and other micropollutants before treated water is discharged to the environment. Advanced treatment methods are also applicable to improving microplastic removal from wastewater.
Fate and Removal of Microplastics from Industrial Wastewaters
This review examines how industrial wastewater treatment plants handle microplastic contamination worldwide. Researchers found that treatment effectiveness varies widely depending on the industry and the technologies used. The paper highlights that industrial sources are a significant but often overlooked contributor to microplastic pollution in waterways.
How to decrease pharmaceuticals in the environment? A review
This review examines strategies for reducing pharmaceutical pollution in the environment, which is relevant to microplastic research because pharmaceuticals often co-occur with plastic contaminants in waterways. The authors ranked approaches from upstream solutions like greener drug design and better prescription practices to downstream technologies like advanced water treatment. The study concludes that preventing pharmaceutical pollution at its source is more effective and sustainable than relying solely on end-of-pipe treatment technologies.